OCEA (Ocean Biomedical Inc) Sof foyda

OCEA (Ocean Biomedical) - kompaniyaning tovar belgisi

Ocean Biomedical, Inc. (OCEA) akademik fan va bozor o'rtasida ko'prik vazifasini o'tab, onkologik ishlanmalarning joriy etilishini tezlashtiradi. Emitent laboratoriya emissiyalarini tozalashni modernizatsiya qilish orqali ESG standartlariga qat'iy rioya qiladi. Ushbu foyda grafigi kompaniyaning zarbalarga moslashuvini aniq namoyish etadi, bunda 0.00 belgisi ushbu parametrni xarakterlaydi. Qiymatning oshishi pipeline atrofidagi spekulyatsiyalar va sog'liqni saqlash gigantlari bilan yirik litsenziyalash shartnomalariga bo'lgan kutishlar hisobiga yuz bermoqda.

OCEA (Ocean Biomedical, Inc.) Sof foyda tarixi 28.04.2023dan 24.05.2025gacha

Ocean Biomedical (OCEA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Ocean Biomedical Corp|OCEA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Ocean Biomedical Corp|OCEA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Ocean Biomedical|OCEA - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi oceanbiomedical.com|OCEA - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Ocean Biomedical, Inc.|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Ocean Biomedical Inc|OCEA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Ocean Biomedical Corp|OCEA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Ocean Biomedical|Shoshilinch likvidlik oceanbiomedical.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
OCEA - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Ocean Biomedical, Inc.
Ocean Bio asosiy tovari

Ocean Biomedical, Inc. (OCEA) ning operatsion muvaffaqiyati kompaniyaning barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyingi yakuniy moliyaviy natijani aks ettiruvchi foyda trayektoriyasida namoyon bo'lmoqda. Ushbu ko'rsatkich biznesning tartibga soluvchi to'siqlar va xomashyo ta'minoti uzilishlariga nisbatan barqarorligini ochib beradi, bu esa investorlarga biofarmatsevtika ishlanmalarining haqiqiy samaradorligini zarar ko'rayotgan korxonaning haddan tashqari qimmat baholangan aktivlarini sotib olish xavflaridan ajratish imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Pharming Corp|NKTR: Sof foyda|Sof daromad upstreambio.com|ZBIO (Zenas Biopharma) - Sof foyda|Kompaniyaning sof daromadi Immunome Inc IMNM|Sof foyda GOSS|Sof foyda KalVista Corp (KALV)|Kompaniyaning sof foydasi Septerna Inc SEPN|PVLA: Kompaniya foydasi|SVRA: Sof daromad|Yakuniy foyda RIGL (Rigel Pharma)|ANAB: Sof foyda|ATXS (Astria Corp) - Kompaniyaning sof foydasi|ENGN (enGene Holdings Inc.) - Sof foyda|rapt.com (RAPT) - Sof moliyaviy natija|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|ACRS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Kyverna KYTX|TLSA - Sof daromad|Cabaletta Bio, Inc. - Sof foyda|Kompaniyaning sof daromadi ventyxbio.com|THTX: Sof foyda|Kompaniya foydasi AVTX|ELDN (Eledon) - Sof foyda|Agenus, Inc (AGEN) - Sof moliyaviy natija|Sof foyda CLYM|Sof daromad zurabio.com ZURA|Sof foyda ATYR (aTyr Pharma)|Sof foyda Adagene Inc ADAG|IMA - Kompaniyaning sof foydasi|STTK: Kompaniyaning sof foydasi|EQ (equilliumbio.com) - Sof daromad|Connect Biopharma Holdings Limited - Yakuniy foyda|IMUX (Immunic Therapeutics) - Sof foyda|Atara Biotherapeutics Inc (ATRA) - Sof moliyaviy natija|Kompaniyaning sof foydasi InflaRx N.V. (IFRX)|X4 Pharmaceuticals, Inc - Kompaniya foydasi|Sof foyda ACET (Adicet Bio, Inc.)|CELU - Sof daromad|INMB: Sof daromad|Sof moliyaviy natija Barinthus Biotherapeutics PLC BRNS|Kezar Life Sciences, Inc (KZR) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi SAB Biotherapeutics Inc (SABS)|AKTX (Akari Therapeutics) - Sof foyda|Sof daromad Enlivex Therapeutics, Ltd. (ENLV)|Sof foyda QTTB|GOVX - Kompaniyaning sof daromadi|Sof foyda EDSA (Edesa)|Sof foyda iBio Corporation IBIO|CARM - Kompaniyaning sof foydasi|Soliqdan keyingi foyda XTLB|BOLT: Sof foyda|HCW Biologics - Yakuniy foyda|APVO (Aptevo Therapeutics, Inc.) - Sof foyda|Sof foyda aimimmuno.com|Kompaniyaning sof foydasi Aditxt (ADTX)|GRI (gribio.com) - Yakuniy foyda|Kompaniyaning sof foydasi XORTX Therapeutics XRTX|HIND - Sof daromad|Revelation Bio - Sof foyda|INDP - Sof foyda|SCNI (Scinai Immunotherapeutics) - Sof daromad|CalciMedica - Yakuniy foyda|AFMD (Affimed NV) - Sof foyda|Allakos Therapeutics (ALLK) - Sof moliyaviy natija|Kompaniyaning sof foydasi HOOKIPA Pharma Inc. (HOOK)|Sof daromad igmbio.com IGMS|Kompaniyaning sof foydasi iTeos Therapeutics ITOS|TCBP - Sof daromad|THRD: Sof daromad